Comparing the Daily Versus the Intermittent Regimens of the Anti-Tubercular Chemotherapy in the Initial Intensive Phase in Non-HIV, Sputum Positive, Pulmonary Tuberculosis Patients
ABSTRACT Background: Tuberculosis (TB) is a major health problem in the universe and India is no longer exempted from this crisis. The emergence of HIV and MDRTB (Multi Drug Resistant Tuberculosis) have further made the situation critical. Aims: Our aim was to compare the efficacy of the daily a...
Main Authors: | Pranab Kumar Mandal, Abhijit Mandal, Sujit Kumar Bhattacharyya |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2013-02-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/2750/25-%205122_E(C)_PF1(M)_F(P)_PF1(P)_PFA(N)_OLF_u_(P).pdf |
Similar Items
-
Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study
by: Geetha Ramachandran, et al.
Published: (2023-01-01) -
Effectiveness of daily directly observed treatment, short-course regimen among patients registered for treatment at an urban primary health center in Bengaluru
by: Huluvadi Shivalingaiah Anwith, et al.
Published: (2019-01-01) -
Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study [version 1; peer review: 1 approved, 2 approved with reservations]
by: Himani Kotian, et al.
Published: (2022-04-01) -
Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study [version 2; peer review: 1 approved, 2 approved with reservations]
by: Himani Kotian, et al.
Published: (2022-07-01) -
Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
by: Abdul Wahid, et al.
Published: (2022-09-01)